Related Experiment Video
Updated: May 19, 2026

Preparation of Naringenin Solution for In Vivo Application
Published on: August 10, 2021
Partial inhibition of aldose reductase by nitazoxanide and its molecular basis
Xuehua Zheng1, Liping Zhang, Weijia Chen
1School of Pharmaceutical Sciences, Sun Yat-sen University, Guangzhou 510006 (China).
Abstract:
A little is more than enough: Aldose reductase (AR) is a potential target in a wide range of diseases but its utility may be limited by the side effects caused by complete inhibition. Furthermore, known inhibitors of AR have suffered in clinical evaluation due to poor bioavailability. Here, the clinically used antiprotozoal drug nitazoxanide with proven bioavailability has been shown to partially inhibit AR, potentially circumventing the negatives effects of complete enzyme inhibition.
Related Concept Videos
Phase I Reactions: Reductive Reactions
Preparation of Amines: Reduction of Oximes and Nitro Compounds
Though catalytic hydrogenation can reduce nitrobenzenes, the reduction is nonselective in the presence of other functional groups. For instance, if nitrobenzene contains an aldehyde group,...
Antihypertensive Drugs: Direct Renin Inhibitors
Pharmacogenetics of Phase II Enzymes: N-acetyltransferase, Thiopurine S-methyltransferase, UDP-glucuronosyltransferase
Antihypertensive Drugs: Thiazide-Class Diuretics
Aryldiazonium Salts to Azo Dyes: Diazo Coupling
